gefitinib has been researched along with n-vinyl-2-pyrrolidinone in 1 studies
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (n-vinyl-2-pyrrolidinone) | Trials (n-vinyl-2-pyrrolidinone) | Recent Studies (post-2010) (n-vinyl-2-pyrrolidinone) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 7,533 | 228 | 2,213 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bal, R; Basak, S; Bisht, G; Kandpal, ND; Karki, N; Pal, M; Sahoo, NG; Tiwari, H; Verma, RK | 1 |
1 other study(ies) available for gefitinib and n-vinyl-2-pyrrolidinone
Article | Year |
---|---|
Functionalized graphene oxide as a nanocarrier for dual drug delivery applications: The synergistic effect of quercetin and gefitinib against ovarian cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Delivery Systems; Female; Gefitinib; Graphite; Humans; Ovarian Neoplasms; Povidone; Quercetin | 2019 |